FSD Pharma Inc.
Hedge Funds Holdings
Last updated:
FSD Pharma Inc.‘s stocks are currently a part of 7 hedge funds’ portfolios, which represents 1% of the total amount of its stocks outstanding. This makes up a total of 387.35K shares of FSD Pharma Inc.. Compared to the previous quarter, the number fell by -31.16% or -175.30K shares fewer. As for the holding position changes, 42.86% (3) of current hedge fund investors increased the number of shares held, 14.29% (1) of current holders sold a part of the shares held.
Hedge funds holding FSD Pharma (Q2 2018 – Q1 2023)
| Q2 2018 | 1 |
|---|---|
| Q3 2018 | 2 |
| Q4 2018 | 2 |
| Q1 2019 | 1 |
| Q2 2019 | 1 |
| Q3 2019 | 1 |
| Q4 2019 | 1 |
| Q1 2020 | 3 |
| Q2 2020 | 5 |
| Q3 2020 | 11 |
| Q4 2020 | 11 |
| Q1 2021 | 15 |
| Q2 2021 | 15 |
| Q3 2021 | 14 |
| Q4 2021 | 16 |
| Q1 2022 | 15 |
| Q2 2022 | 12 |
| Q3 2022 | 13 |
| Q4 2022 | 13 |
| Q1 2023 | 7 |
Hedge funds changes in FSD Pharma positions (Q2 2018 – Q1 2023)
| Q2 2018 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2018 | 1 | 0 | 0 | 0 | 1 |
| Q4 2018 | 0 | 0 | 1 | 0 | 1 |
| Q1 2019 | 0 | 0 | 0 | 1 | 0 |
| Q2 2019 | 0 | 0 | 1 | 0 | 0 |
| Q3 2019 | 0 | 0 | 0 | 0 | 1 |
| Q4 2019 | 1 | 0 | 0 | 1 | -1 |
| Q1 2020 | 2 | 0 | 0 | 0 | 1 |
| Q2 2020 | 2 | 2 | 0 | 0 | 1 |
| Q3 2020 | 7 | 2 | 2 | 1 | -1 |
| Q4 2020 | 5 | 3 | 2 | 5 | -4 |
| Q1 2021 | 7 | 3 | 3 | 3 | -1 |
| Q2 2021 | 4 | 5 | 2 | 4 | 0 |
| Q3 2021 | 6 | 2 | 2 | 7 | -3 |
| Q4 2021 | 8 | 3 | 2 | 6 | -3 |
| Q1 2022 | 3 | 5 | 3 | 3 | 1 |
| Q2 2022 | 2 | 4 | 1 | 5 | 0 |
| Q3 2022 | 3 | 3 | 3 | 2 | 2 |
| Q4 2022 | 2 | 4 | 3 | 2 | 2 |
| Q1 2023 | 0 | 3 | 1 | 0 | 3 |
Hedge funds changes in FSD Pharma stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 808,000 | 40,000 |
| Q4 2020 | 1,025,000 | 60,000 |
| Q1 2021 | 1,388,000 | 903,000 |
| Q2 2021 | 812,000 | 486,000 |
| Q3 2021 | 804,000 | 370,000 |
| Q4 2021 | 269,000 | 120,000 |
| Q1 2022 | 211,000 | 78,000 |
| Q2 2022 | 77,000 | 58,000 |
| Q3 2022 | 32,000 | 3,000 |
| Q4 2022 | 60,831 | 7,071 |
| Q1 2023 | 9,199,000 | 1,861,000 |